SINGLETON J MATTHEW bought VKTX
January 2, 2026 · Form 4 insider transaction
SINGLETON J MATTHEW bought 3,150 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,150
Price
$0.00
Total value
N/A
InsiderSINGLETON J MATTHEW
RoleDirector
SecurityCommon Stock, par value $0.00001 per share
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after12,650
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. All shares subject to the RSU shall vest on the one year anniversary of the grant date of the award.